Dermatology Focus Blueberry concentrates on skin diseases with programs in Onychomycosis, Tinea Pedis, Acne, and Atopic Dermatitis, presenting a specialized target deck for dermatology-focused CROs, contract research services, or licensing partnerships.

Small Team Growth With a lean team and ongoing fundraising history, there are clear avenues for collaboration, co-development deals, or minority investment to scale preclinical and early clinical programs.

Clinical Efficiency Blueberry emphasizes smart, agile clinical designs to accelerate trials and cut cost, offering opportunities to partner on trial design, data management, regulatory strategy, or shared risk development models.

Leadership Access Decisions makers include a Clinical Science Lead and independent director, plus a Clinical Project Manager, enabling direct engagement for partnerships, service proposals, or joint development agreements.

Funding Experience Past funding from NPIF and Maven Equity Finance signals openness to external financing collaborations, syndication, grants, or milestone-based funding partnerships to advance pipeline.